Sheel Biotech
add_icon

Sheel Biotech

44.60
+2.05
(4.82%)
Market Cap
90.77 Cr
PE Ratio
-
Volume
16,000.00
Day High - Low
44.60 - 44.30
52W High-Low
95.55 - 37.80
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
90.77 Cr
EPS
6.69
PE Ratio
-
PB Ratio
-
Book Value
62.40
EBITDA
16.28
Dividend Yield
0.00 %
Return on Equity
12.68
Debt to Equity
0.26
Forecast For
Actual

Company News

View All News
Caret
positive
Sheel Biotech reported a 9.3% rise in net profit to ₹117.56 crore for FY26, with revenue from operations increasing 8.1% to ₹1,100.22 crore. The board approved the audited financial results on May 28, 2026.
positive
Sheel Biotech Limited signed an MoU with ICAR-CISH under the Fruit Horizon program on May 20, 2026. The partnership focuses on technology commercialization to enhance fruit innovation.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
358.15
#1 15,477.80
27.43
1,088.50
19.65
#1 427
27.65
54.19
611.00
8,271.60
114.22
2,440.18
20.56
53
79.56
70.57
1,144.00
8,060.62
20.06
932.06
7.80
401
5.08
44.00
419.35
5,924.25
42.52
#1 15,981.50
20.55
42
145.88
68.83
611.50
5,510.72
15.85
669.17
3.75
361
31.96
67.32
23.50
5,462.30
#1 15.52
833.38
#1 1,66,576.00
174
218.33
72.63
447.10
5,108.66
479.02
1,795.81
27.39
5
#1 300.00
51.86
302.75
4,984.40
16.61
2,487.18
0.48
293
-18.95
54.60
138.50
3,947.25
-360.00
0.99
-87.31
-14
-54.55
48.55
158.75
3,364.95
-31.43
1,450.81
31.55
-157
27.80
42.45
Growth Rate
Revenue Growth
7.55 %
Net Income Growth
9.34 %
Cash Flow Change
1,101.09 %
ROE
-12.01 %
ROCE
-0.85 %
EBITDA Margin (Avg.)
-2.97 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
2026
TTM
Revenue
63
71
80
93
102
110
0
Expenses
57
64
71
78
87
94
0
EBITDA
7
7
9
15
16
16
0
Operating Profit %
10 %
9 %
11 %
16 %
15 %
15 %
0 %
Depreciation
1
1
1
1
1
1
0
Interest
1
1
2
2
2
2
0
Profit Before Tax
5
5
6
12
13
14
0
Tax
0
0
1
2
2
2
0
Net Profit
5
5
5
11
11
12
0
EPS in ₹
11.58
3.11
3.50
7.22
7.21
6.69
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
82
93
94
106
113
146
Fixed Assets
8
8
8
7
8
13
Current Assets
74
83
83
95
101
128
Capital Work in Progress
0
0
0
0
0
4
Investments
0
0
0
0
0
30
Other Assets
75
85
86
99
106
0
Total Equity & Liabilities
82
93
94
106
113
146
Current Liabilities
13
20
21
23
24
17
Non Current Liabilities
12
14
10
11
5
2
Total Equity
57
60
64
73
84
127
Reserve & Surplus
53
56
59
69
69
107
Share Capital
4
4
4
4
15
20

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
-0
-0
0
-0
Investing Activities
-2
-2
-0
-2
Operating Activities
2
9
-1
9
Financing Activities
-0
-7
2
-7

Share Holding

% Holding
Nov 2024
Sept 2025
Oct 2025
Mar 2026
Promoter
96.99 %
96.99 %
71.26 %
72.30 %
FIIs
0.00 %
0.00 %
2.28 %
0.00 %
DIIs
0.00 %
0.00 %
10.25 %
9.49 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
12.09 %
10.89 %
Others
3.01 %
3.01 %
4.13 %
7.32 %
No of Share Holders
33
33
636
395

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.5 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
15 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 Nov 2025 77.50 74.25
28 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2026 42.10 45.40

Technical Indicators

RSI(14)
Neutral
44.52
ATR(14)
Volatile
2.20
STOCH(9,6)
Neutral
48.03
STOCH RSI(14)
Neutral
30.47
MACD(12,26)
Bullish
0.04
ADX(14)
Weak Trend
19.00
UO(9)
Bearish
44.70
ROC(12)
Downtrend And Accelerating
-7.50
WillR(14)
Neutral
-56.33